Edwards Lifesciences

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When did Edwards Lifesciences establish its presence in Israel?

Edwards Lifesciences established its presence in Israel in December 2003, following the acquisition of Percutaneous Valve Technologies.

What is the primary focus of the Edwards Israel Innovation Center (EIIC)?

The Edwards Israel Innovation Center (EIIC) focuses on developing early-stage cardiovascular technologies.

When did Edwards Lifesciences acquire Innovalve Bio Medical?

Edwards Lifesciences acquired the Israeli company Innovalve Bio Medical on July 15, 2024.

When did Edwards Lifesciences acquire Valtech Cardio?

Edwards Lifesciences acquired the Israeli company Valtech Cardio for $1 billion on November 28, 2016.

When did Edwards Lifesciences acquire Percutaneous Valve Technologies (PVT)?

Edwards Lifesciences acquired Percutaneous Valve Technologies (PVT) on December 16, 2003.

When did Edwards Lifesciences become a public company?

Edwards Lifesciences became a public company with an IPO on the NYSE in July 1998.

What is the approximate number of employees at Edwards Lifesciences' Israeli R&D center?

The Edwards Israel Innovation Center (EIIC) has approximately 51-200 employees.

What is Edwards Lifesciences' primary business sector?

Edwards Lifesciences operates in the medical devices and equipment and supplies sector, focusing on patient-focused medical innovations for heart disease and critical care monitoring.

Tags